Resection of Liver Metastases before Primary, After Complete Response to M-Folfirinox in Pancreatic Carcinoma: A Case Report

Angélica Lucchese

Department of Surgical Oncology, Hospital Santa Rita, Brazil

^*Correspondance to: Angélica Lucchese 

 PDF  Full Text Case Report | Open Access

Abstract:

Approximately 50% of new pancreatic adenocarcinoma presented liver metastases at diagnosis, with a median survival of less than 1 year. The only curative treatment of pancreatic adenocarcinoma is surgery, but once distant metastases are detected, the guidelines do not recommend any resection.We describe a case of pancreatic ductal adenocarcinoma with synchronous liver metastases that presented a complete radiologic response to neoadjuvant chemotherapy that underwent resection for liver metastases before the pancreatic resection. The patient has now 2 years from the first resection without recurrence. This case suggests that a patient with good response to neoadjuvant chemotherapy and with an expected R0 resection could be an ideal candidate for surgery, even for a liver first approach.

Keywords:

Pancreatic cancer; Liver metastases; Liver resection; Chemotherapy

Cite the Article:

Lucchese A. Resection of Liver Metastases before Primary, After Complete Response to M-Folfirinox in Pancreatic Carcinoma: A Case Report. Clin Oncol. 2018; 3: 1542.